2011
DOI: 10.1093/humrep/der145
|View full text |Cite
|
Sign up to set email alerts
|

No evidence for the presence of oogonia in the human ovary after their final clearance during the first two years of life

Abstract: We found no evidence for the presence of oogonia in the human ovary after their final clearing during the first 2 years. We suggest that perinatal medullary WB and FWB give rise to the groups of small, healthy follicles in the medulla.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
52
0

Year Published

2012
2012
2017
2017

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 67 publications
(55 citation statements)
references
References 55 publications
3
52
0
Order By: Relevance
“…3). However, many labs could not confirm the presence of oocyte stem cells in mouse (Eggan et al 2006, Lei & Spradling 2013 and human (Byskov et al 2011). Moreover, recent work showed uncertainty in the specificity of antibodies used for the isolation of murine and human oocyte stem cells (Albertini & Gleicher 2015), and the inability of follicle formation after grafting these oocyte stem cells into mouse postnatal ovaries (Zhang et al 2015).…”
Section: Limitation Of Iva Treatment and Future Studies: The Prospectmentioning
confidence: 99%
“…3). However, many labs could not confirm the presence of oocyte stem cells in mouse (Eggan et al 2006, Lei & Spradling 2013 and human (Byskov et al 2011). Moreover, recent work showed uncertainty in the specificity of antibodies used for the isolation of murine and human oocyte stem cells (Albertini & Gleicher 2015), and the inability of follicle formation after grafting these oocyte stem cells into mouse postnatal ovaries (Zhang et al 2015).…”
Section: Limitation Of Iva Treatment and Future Studies: The Prospectmentioning
confidence: 99%
“…Thus, retention in small cysts might represent the way to preserve undifferentiated PGCs within the post-natal ovary. Some evidence exists that in the mouse and in some primate species, including humans pre-meiotic proliferating PGCs/oogonia remain in the post-natal ovary during the first period after birth perhaps until puberty (Motta & Makabe 1982, McClellan et al 2003, Johnson et al 2004, Telfer 2004, Byskov et al 2011, Zhang et al 2012. The question of whether any of these proliferating germ cells become follicle-enclosed oocytes remains open.…”
Section: Fgscs Could Originate From Undifferentiated Pgcs or A Subpopmentioning
confidence: 99%
“…This is associated with widespread changes in protein expression, including downregulation of pluripotency factors, OCT4, NANOG, C-KIT, and LIN28 (8,11,(17)(18)(19)(20), and upregulation of markers of germ cell differentiation and meiosis, such as VASA, DAZL, STRA8, and SYCP3 (5,6,20). In human fetal ovaries, meiotic entry is initiated asynchronously from around GW 10-11 and constitutes the transition from oogonia to oocytes (17,20,22,41). This was recently confirmed by the presence of γH2AX-positive (marks double-strand breaks) oogonia at GW 10 (5) and SCP3-positive oogonia from GW 12-14 (42,43).…”
Section: Initiation Of Meiosis In Fetal Ovariesmentioning
confidence: 99%
“…In fetal ovaries, germ cells are termed oogonia once they reside within the gonad (17), and they irreversibly commit to the female developmental pathway when initiating the first meiotic division (5,6). During oogenesis, the mitotically dividing oogonia differentiate to primary oocytes by initiation of meiosis, coinciding with a permanent downregulation of pluripotency genes, i.e., OCT4, NANOG, C-KIT, and LIN28 (8,11,(17)(18)(19)(20).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation